Literature DB >> 22512241

ApoE and TDP-43 neuropathology in two siblings with familial FTLD-motor neuron disease.

Keith A Vossel1, Nga Bien-Ly, Aubrey Bernardo, Katya Rascovsky, Anna Karydas, Gil D Rabinovici, Manu Sidhu, Eric J Huang, Bruce L Miller, Yadong Huang, William W Seeley.   

Abstract

Frontotemporal lobar degeneration with motor neuron disease (FTLD-MND) is characterized by neuronal cytoplasmic inclusions containing TDP-43. Apolipoprotein E4 (apoE4), derived from the apoE ϵ4 allele, enhances brain atrophy in FTLD through unknown mechanisms. Here, we studied two siblings with C9ORF72-linked familial FTLD-MND, an apoE ϵ4 homozygote and an apoE ϵ3 homozygote. The apoE ϵ4 homozygote had more cognitive-behavioral symptoms, fronto-insulo-temporal atrophy, and apoE fragments and aggregates in the anterior cingulate cortex. ApoE formed complexes with TDP-43 that were more abundant in the apoE ϵ4 homozygote. Although differences seen in a sibling pair could arise due to chance, these findings raise the possibility that apoE4 exacerbates brain pathology in FTLD through formation of neurotoxic apoE fragments and interactions with TDP-43.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22512241      PMCID: PMC3655113          DOI: 10.1080/13554794.2012.667124

Source DB:  PubMed          Journal:  Neurocase        ISSN: 1355-4794            Impact factor:   0.881


  20 in total

1.  Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons.

Authors:  Y Huang; X Q Liu; T Wyss-Coray; W J Brecht; D A Sanan; R W Mahley
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

2.  Dose dependent effect of APOE epsilon4 on behavioral symptoms in frontal lobe dementia.

Authors:  Sebastiaan Engelborghs; Bart Dermaut; Peter Mariën; Anoek Symons; Ellen Vloeberghs; Karen Maertens; Nore Somers; Johan Goeman; Rosa Rademakers; Marleen Van den Broeck; Barbara Pickut; Marc Cruts; Christine Van Broeckhoven; Peter P De Deyn
Journal:  Neurobiol Aging       Date:  2006-02       Impact factor: 4.673

3.  The effects of executive and behavioral dysfunction on the course of ALS.

Authors:  R K Olney; J Murphy; D Forshew; E Garwood; B L Miller; S Langmore; M A Kohn; C Lomen-Hoerth
Journal:  Neurology       Date:  2005-12-13       Impact factor: 9.910

4.  Association of APOE epsilon4 allele with survival in amyotrophic lateral sclerosis.

Authors:  V E Drory; M Birnbaum; A D Korczyn; J Chapman
Journal:  J Neurol Sci       Date:  2001-09-15       Impact factor: 3.181

5.  Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22.

Authors:  B A Hosler; T Siddique; P C Sapp; W Sailor; M C Huang; A Hossain; J R Daube; M Nance; C Fan; J Kaplan; W Y Hung; D McKenna-Yasek; J L Haines; M A Pericak-Vance; H R Horvitz; R H Brown
Journal:  JAMA       Date:  2000-10-04       Impact factor: 56.272

6.  Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzheimer disease.

Authors:  Joel H Kramer; Jennifer Jurik; Sharon J Sha; Kate P Rankin; Howard J Rosen; Julene K Johnson; Bruce L Miller
Journal:  Cogn Behav Neurol       Date:  2003-12       Impact factor: 1.600

7.  The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.

Authors:  J L Cummings; M Mega; K Gray; S Rosenberg-Thompson; D A Carusi; J Gornbein
Journal:  Neurology       Date:  1994-12       Impact factor: 9.910

Review 8.  The neuropathology of FTD associated With ALS.

Authors:  Ian R A Mackenzie
Journal:  Alzheimer Dis Assoc Disord       Date:  2007 Oct-Dec       Impact factor: 2.703

Review 9.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 10.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.

Authors:  R W Mahley
Journal:  Science       Date:  1988-04-29       Impact factor: 47.728

View more
  8 in total

Review 1.  Alzheimer mechanisms and therapeutic strategies.

Authors:  Yadong Huang; Lennart Mucke
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

2.  Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE ε4 haplotype status: a community-based cohort study.

Authors:  Hyun-Sik Yang; Lei Yu; Charles C White; Lori B Chibnik; Jasmeer P Chhatwal; Reisa A Sperling; David A Bennett; Julie A Schneider; Philip L De Jager
Journal:  Lancet Neurol       Date:  2018-08-06       Impact factor: 44.182

3.  Dementia After Moderate-Severe Traumatic Brain Injury: Coexistence of Multiple Proteinopathies.

Authors:  Kimbra Kenney; Diego Iacono; Brian L Edlow; Douglas I Katz; Ramon Diaz-Arrastia; Kristen Dams-O'Connor; Daniel H Daneshvar; Allison Stevens; Allison L Moreau; Lee S Tirrell; Ani Varjabedian; Anastasia Yendiki; Andre van der Kouwe; Azma Mareyam; Jennifer A McNab; Wayne A Gordon; Bruce Fischl; Ann C McKee; Daniel P Perl
Journal:  J Neuropathol Exp Neurol       Date:  2018-01-01       Impact factor: 3.685

Review 4.  C9ORF72 mutations in neurodegenerative diseases.

Authors:  Ying Liu; Jin-Tai Yu; Yu Zong; Jing Zhou; Lan Tan
Journal:  Mol Neurobiol       Date:  2013-08-10       Impact factor: 5.590

5.  Clinical Characteristics of C9ORF72-Linked Frontotemporal Lobar Degeneration.

Authors:  Anna-Lotta Kaivorinne; Michaela K Bode; Liisa Paavola; Hannu Tuominen; Mika Kallio; Alan E Renton; Bryan J Traynor; Virpi Moilanen; Anne M Remes
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2013-08-20

Review 6.  TDP-43 Pathology in Alzheimer's Disease.

Authors:  Axel Meneses; Shunsuke Koga; Justin O'Leary; Dennis W Dickson; Guojun Bu; Na Zhao
Journal:  Mol Neurodegener       Date:  2021-12-20       Impact factor: 14.195

7.  Nuclear accumulation of CHMP7 initiates nuclear pore complex injury and subsequent TDP-43 dysfunction in sporadic and familial ALS.

Authors:  Alyssa N Coyne; Victoria Baskerville; Benjamin L Zaepfel; Dennis W Dickson; Frank Rigo; Frank Bennett; C Patrick Lusk; Jeffrey D Rothstein
Journal:  Sci Transl Med       Date:  2021-07-28       Impact factor: 19.319

Review 8.  APOE2: protective mechanism and therapeutic implications for Alzheimer's disease.

Authors:  Zonghua Li; Francis Shue; Na Zhao; Mitsuru Shinohara; Guojun Bu
Journal:  Mol Neurodegener       Date:  2020-11-04       Impact factor: 18.879

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.